WHO: Genomic Studies Favor Rich Nations, Under 5% in LMICs

A new WHO analysis reveals that fewer than 5% of disease-focused genomic studies occur in low and middle-income countries (LMICs), while over 80% are concentrated in high-income nations. This disparity limits the application of genomic insights to global health priorities, particularly infectious diseases prevalent in LMICs.

• Under 5% of genomic studies are conducted in low/middle-income countries.
• Over 80% of genomic clinical studies are concentrated in high-income nations.
• India features among the top 20 countries for genomic studies.
• Infectious diseases, global health priorities, account for only 3% of studies.
• Cancer and rare diseases dominate over 75% of genomic research.
• WHO calls for more inclusive and geographically diverse genomic research.

Read the full story on Quick Digest.